More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia

por Muluneh, Atalay Goshu, Merid, Mehari Woldemariam, Gelaye, Kassahun Alemu, Tilahun, Sewbesew Yitayih, Teshager, Nahom Worku, Abereha, Aklilu Yiheyis, Sugamo, Kalkidan Samuel, Yimer, Mulugeta Ayalew, Kassa, Getahun Molla
Publicado 2022